Home » Topics » Regulatory

Regulatory
RSS

FDA approves pediatric indication for Tamiflu

Dec. 18, 2000

FDA clears new dose of Concerta for ADHD

Dec. 18, 2000

ODAC unanimously recommends approval of Femara as first-line breast cancer treatment

Dec. 15, 2000

New Claritin formulation receives FDA marketing approval

Dec. 14, 2000

FDA approves second indication for Antizol

Dec. 13, 2000

Galenic formulations of antithrombotic agents for s.c. administration

Dec. 12, 2000

FDA approves new indications for Prevacid

Dec. 12, 2000

Health Canada approves Asmanex Twisthaler for treatment of asthma

Dec. 12, 2000

Myobloc is first FDA-approved treatment for cervical dystonia

Dec. 11, 2000

FDA approves Protopic for the treatment of eczema

Dec. 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.